Delivery Order SPE2DB20D3101-SPE2DB25FRHB4

Award Date 4/17/25
Potential Completion Date 4/18/25
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,289.24, is for the delivery of 4,567,969,223 units of the medication Teriparatide 560MCG/2.24ML Pen 2.24ML. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,943,582 units of the medication teriparatide 560mcg/2.24ml pen, with a ceiling value of $11,646.66 and a performance period through April 17, 2025. The contract is not set aside and was awarded on April 16, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,722.65, is for the supply of 4,567,957,364 units of the medication Teriparatide 560mcg/2.24ml Pen 2.24ml. The contract is a Firm Fixed Price arrangement with an ultimate completion date of April 18, 2025. This order is not set aside for any specific business category. AmerisourceBergen Drug...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution services company. The $2,598.99 firm fixed price contract is for the supply of teriparatide 620 mcg/2.48 ml medication. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug teriparatide 560 mcg/2.24 ml pen in a 2.24 ml quantity. The contract has a firm fixed price of $3,167.44 and a completion date of May 22, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,278.41 contract is for the supply of 4567875629 TERIPARATIDE 560MCG/2.24ML PEN 2.24ML, a prescription medication. The contract has an ultimate completion date of April 11, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of Teriparatide 620 mcg/2.48 ml medication, with a total ceiling value of $2,598.99 and a period of performance through April 9, 2024. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) awarded to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,630,664 units of teriparatide 600 mcg/2.4 ml pen 2.4 ml, a specialty medication used in the treatment of certain medical conditions. The contract has a firm fixed price of $7,705.99 and a performance period ending on May 17, 2024. AmerisourceBergen holds a significant...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $29,830.25 firm fixed-price delivery order is for the supply of 4,566,054,436 units of the drug Teriparatide 600 mcg/2.4 ml pen. The contract has an ultimate completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
This is a $4,767.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of TERIPARATIDE 620 MCG/2.48 ML 2.48ML, a prescription medication, with an ultimate completion date of April 22, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB25FRHB4
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,947.18, is for the delivery of 4,567,955,867 units of the medication teriparatide 620 mcg/2.48 ml. The contract has an ultimate completion date of April 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the DLA Troop Support Medical through December 2026. The contract is not set aside and is open to full and open competition.

Generated 7/17/25, 2:25 PM